WASHINGTON - Federal health officials have expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Fri, 10/02/2015 - 12:31pm
WASHINGTON - Federal health officials have expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.